Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chart: FDA October 2004 Report of Medical Device Approvals

This article was originally published in The Gray Sheet

Executive Summary

FDA October 2004 Report of Medical Device Approvals

You may also be interested in...



First Spring Sign: Chinese Vaccines Maker Gets $290m Funding

With vaccines perhaps the ultimate weapon to fight the coronavirus, a developer in China sees a big chunk of investment with potentially more companies to see funding coming.

Belgium Bans COVID-19 Antibody Self-Tests But UK Goes Ahead

While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers they are not sufficiently accurate to be used in the pandemic.

Coronavirus Update: Can IL-6 Drugs Cut Deaths? Kevzara Trials Starts In Worst Hit Countries

A round up of news from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.

UsernamePublicRestriction

Register

MT021202

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel